Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Trypanosomiasis Sleeping disease.php on line 2
Trypanosomiasis Sleeping disease
LE WE PMID CA
Trypanosomiasis Sleeping disease2821Trypanosomiasis Schlafkrankheit

Acanthamoeba

Apicomplexan parasites

Apolipoprotein LI

Balamuthia mandrillaris

CD163

Chagas disease

CNS (Infection)

Echinococcosis

Entamoeba

Fexinidazole

Giardia lamblia

Haptoglobin related protein

Haptoglobin

Heart (Cardiomyopathy BASKET)

Heme oxygenase

Leishmaniasis

Malaria

Methylglyoxal

Microneme

Microsporidiosis

Naegleria fowlerii

Paragonimiasis

Plasmodium knowlesi

Regulatory T cell

Rhoptries

Schistosoma

Sparganosis

Trypanosomiasis Sleeping disease

1998  
1
Human African trypanosomiasis: an emerging public health crisis.
[9830201] Br Med Bull 54(2): 341-55 (1998)
1967  
2
Some principles of the immunology of trypanosomiasis.
[4866448] Bull World Health Organ 37(2): 177-93 (1967)
1967  
3
Trends in research on the immunology of trypanosomiasis.
[4866447] Bull World Health Organ 37(2): 165-75 (1967)
1963  
4
Tsetse-fly physiology. A review of recent advances and current aims.
[14017193] Bull World Health Organ 28(5-6): 703-9 (1963)
1963  
5
A review of recent knowledge of the ecology of the main vectors of trypanosomiasis.
[13928678] Bull World Health Organ 28(5-6): 671-701 (1963)
2007  
6
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.
[17618313] Br J Pharmacol 152(8): 1155-71 (2007)
2002  
7
1995  
8
Control of gene expression in trypanosomes.
[7603410] Microbiol Rev 59(2): 223-40 (1995)
1985  
9
Molecular biology of trypanosome antigenic variation.
[2409439] Microbiol Rev 49(2): 107-25 (1985)
1980  
10
Biology and physiology of the lower Trypanosomatidae.
[6997722] Microbiol Rev 44(1): 140-73 (1980)
1978  
11
Biologically active products from African Trypanosomes.
[368556] Microbiol Rev 42(4): 664-81 (1978)
2006  
12
Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.
[16323101] Clin Infect Dis 42(1): 115-25 (2006)
2005  
13
Regulation of innate and acquired immunity in African trypanosomiasis.
[16179030] Parasite Immunol 27(10-11): 361-71 (2005)
2004  
14
Human African trypanosomiasis: clinical presentation and immune response.
[15771682] Parasite Immunol 26(11-12): 469-76 (2004)
2009  
15
Trypanosome glycosylphosphatidylinositol biosynthesis.
[19724691] Korean J Parasitol 47(3): 197-204 (2009)
2004  
16
Endocytosis, membrane recycling and sorting of GPI-anchored proteins: Trypanosoma brucei as a model system.
[15255888] Mol Microbiol 53(3): 735-44 (2004)
2009  
17
Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.
[19168735] Infect Immun 77(4): 1276-84 (2009)
2001  
18
Analysis of macrophage activation in African trypanosomiasis.
[11358974] J Leukoc Biol 69(5): 685-90 (2001)
2007  
19
Intracellular trafficking in the trypanosomatids.
[17461800] Traffic 8(6): 629-39 (2007)
2004  
20
Human African trypanosomiasis of the CNS: current issues and challenges.
[14966556] J Clin Invest 113(4): 496-504 (2004)
2005  
21
The developmental cell biology of Trypanosoma brucei.
[15654017] J Cell Sci 118(Pt 2): 283-90 (2005)
1999  
22
History of sleeping sickness in East Africa.
[9880477] Clin Microbiol Rev 12(1): 112-25 (1999)
2008  
23
African sleeping sickness.
[18321959] BMJ 336(7646): 679-80 (2008)
2004  
24
Why trypanosomes cause sleeping sickness.
[15304634] Physiology (Bethesda) 19(-): 198-206 (2004)
2009  
25
Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging.
[19380867] Blood 114(4): 764-71 (2009)
2011  
26
Methylglyoxal metabolism in trypanosomes and leishmania.
[21310261] Semin Cell Dev Biol 22(3): 271-7 (2011)
2006  
27
What can we learn from trypanosomes?
[16874079] Autophagy 2(2): 63-4 (2006)
2010  
28
Composition and sensory function of the trypanosome flagellar membrane.
[20580599] Curr Opin Microbiol 13(4): 466-72 (2010)
2010  
29
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy.
[20730015] Vasc Health Risk Manag 6(-): 593-601 (2010)
2004  
30
Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease.
[15057339] Mem Inst Oswaldo Cruz 99(1): 1-12 (2004)
2008  
31
Trypanosoma (Duttonella) vivax: its biology, epidemiology, pathogenesis, and introduction in the New World--a review.
[18368231] Mem Inst Oswaldo Cruz 103(1): 1-13 (2008)
2008  
32
Electron microscopy of trypanosomes--a historical view.
[18660983] Mem Inst Oswaldo Cruz 103(4): 313-25 (2008)
2009  
33
Structural organization of Trypanosoma cruzi.
[19753463] Mem Inst Oswaldo Cruz 104 Suppl 1(-): 89-100 (2009)
2009  
34
Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors--how to make a dream come true.
[19753478] Mem Inst Oswaldo Cruz 104 Suppl 1(-): 226-35 (2009)
2009  
35
The effects of nitric oxide on the immune system during Trypanosoma cruzi infection.
[19753479] Mem Inst Oswaldo Cruz 104 Suppl 1(-): 236-45 (2009)
2009  
36
Activity of trypanosome lytic factor: a novel component of innate immunity.
[19722834] Future Microbiol 4(7): 789-96 (2009)
2007  
37
Cyclic nucleotide signaling mechanisms in trypanosomes: possible targets for therapeutic agents.
[17827441] Mol Interv 7(4): 203-15 (2007)
2004  
38
Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors.
[15223603] Mediators Inflamm 13(3): 139-43 (2004)
2008  
39
Molecular analysis of early host cell infection by Trypanosoma cruzi.
[18508467] Front Biosci 13(-): 3714-34 (2008)
2009  
40
Trypanosoma cruzi: adaptation to its vectors and its hosts.
[19250627] Vet Res 40(2): 26 (2009)
2006  
41
Immunology and immunopathology of African trypanosomiasis.
[17143404] An Acad Bras Cienc 78(4): 645-65 (2006)
2006  
42
Secretory organelles of pathogenic protozoa.
[16710566] An Acad Bras Cienc 78(2): 271-91 (2006)
2009  
43
Environment, interactions between Trypanosoma cruzi and its host, and health.
[19287864] Cad Saude Publica 25 Suppl 1(-): S32-44 (2009)
2011  
44
State of the art in African trypanosome drug discovery.
[21401507] Curr Top Med Chem 11(10): 1255-74 (2011)
2011  
45
Regulatory T cells phenotype in different clinical forms of Chagas' disease.
[21655351] PLoS Negl Trop Dis 5(5): e992 (2011)
2008  
46
The natural progression of Gambiense sleeping sickness: what is the evidence?
[19104656] PLoS Negl Trop Dis 2(12): e303 (2008)
2011  
47
Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies.
[21629508] Open Med Chem J 5(-): 21-30 (2011)
2005  
48
Neuroparasitic infections: cestodes, trematodes, and protozoans.
[16170739] Semin Neurol 25(3): 262-77 (2005)
2011  
49
Neglected disease - african sleeping sickness: recent synthetic and modeling advances.
[21886894] Sci Pharm 79(3): 389-428 (2011)
2009  
50
Perspectives on the Trypanosoma cruzi-host cell receptor interactions.
[19283409] Parasitol Res 104(6): 1251-60 (2009)
2011  
51
Role of heme and heme-proteins in trypanosomatid essential metabolic pathways.
[21603276] Enzyme Res 2011(-): 873230 (2011)
2009  
52
Tsetse flies: genetics, evolution, and role as vectors.
[18992846] Infect Genet Evol 9(1): 124-41 (2009)
2007  
53
Enucleated L929 cells support invasion, differentiation, and multiplication of Trypanosoma cruzi parasites.
[17502387] Infect Immun 75(8): 3700-6 (2007)
2010  
54
The development of drugs for treatment of sleeping sickness: a historical review.
[20219092] Parasit Vectors 3(1): 15 (2010)
2005  
55
Review Article: cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up.
[15860085] Trop Med Int Health 10(5): 395-403 (2005)
2008  
56
Sleeping sickness in West Africa (1906-2006): changes in spatial repartition and lessons from the past.
[18397396] Trop Med Int Health 13(3): 334-44 (2008)
2010  
57
Cell biology of the trypanosome genome.
[21119017] Microbiol Mol Biol Rev 74(4): 552-69 (2010)
2010  
58
Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness.
[21200426] PLoS Negl Trop Dis 4(12): e923 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Trypanosomiasis Sleeping disease.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Trypanosomiasis Sleeping disease.php on line 92